Literature DB >> 23018511

Symptomatic chronic strongyloidiasis in children following treatment for solid organ malignancies: case reports and literature review.

M Norsarwany1, Z Abdelrahman, N Rahmah, N Ariffin, A Norsyahida, B Madihah, M Zeehaida.   

Abstract

Strongyloidiasis is an infection caused by the intestinal nematode Strongyloides stercoralis. Infected healthy individuals are usually asymptomatic, however it is potentially fatal in immunocompromised hosts due to its capacity to cause an overwhelming hyperinfection. Strongyloidiasis could be missed during routine screening because of low and intermittent larval output in stool and variable manifestations of the symptoms. We present two cases of strongyloidiasis occurring in children with solid organ malignancies suspected to have the infection based on their clinical conditions and treatment history for cancer. Both patients were diagnosed by molecular and serological tests and were successfully treated. Thus, strongyloidiasis in patients undergoing intensive treatment for malignancies should be suspected, properly investigated and treated accordingly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018511

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  3 in total

1.  An Analysis of Clinical Characteristics of Strongyloides stercoralis in 70 indigenous patients in Iran.

Authors:  Meysam Sharifdini; Eshrat Beigom Kia; Keyhan Ashrafi; Mostafa Hosseini; Hossein Mirhendi; Mehdi Mohebali; Bahare Kamranrashani
Journal:  Iran J Parasitol       Date:  2014 Apr-Jun       Impact factor: 1.012

2.  Control of chronic Strongyloides stercoralis infection in an endemic community may be possible by pharmacological means alone: Results of a three-year cohort study.

Authors:  Russell Hays; Adrian Esterman; Robyn McDermott
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

Review 3.  Management strategies in the treatment of neonatal and pediatric gastroenteritis.

Authors:  Simona Ciccarelli; Ilaria Stolfi; Giuseppe Caramia
Journal:  Infect Drug Resist       Date:  2013-10-29       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.